Parameter Estimation in a PDE Model for the Spatial Spread of Cocoa Black Pod Disease by Nembot Fomba, C. G., ten Hoopen, G. M., Soubeyrand, S., Roques, L., Ambang, Z., Takam Soh, P.

Get full text

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients by Savic, R M, Barrail-Tran, A, Duval, X, Nembot, G, Panhard, X, Descamps, D, Verstuyft, C, Vrijens, B, Taburet, A-M, Goujard, C, Mentré, F

Get full text

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records by Bertrand, Julie, Barrail-Tran, Aurélie, Fayette, Lucie, Savic, Rada, Goujard, Cécile, Teicher, Elina, Barau, Caroline, Pruvost, Alain, Taburet, Anne-Marie, Mentré, France, Verstuyft, Céline

Get full text

The impact of soil treatments on black pod rot (caused by Phytophthora megakarya) of cacao in Cameroon by Ndoungue, M., Petchayo, S., Techou, Z., Nana, W.G., Nembot, C., Fontem, D., Hoopen, G.M. Ten

Get full text

Modeling the temporal evolution of cocoa black pod rot disease caused by Phytophthora megakarya by Nembot, Christian, Takam Soh, Patrice, Hoopen, Gerben Martijn, Dumont, Yves

Get full text

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial by Chéret, A, Nembot, G, Mélard, A, Lascoux, C, Slama, L, Miailhes, P, Yeni, P, Abel, S, Avettand-Fenoel, V, Venet, A, Chaix, Ml, Molina, Jm, Katlama, C, Goujard, C, Tamalet, C, Raffi, F, Lafeuillade, A, Reynes, J, Ravaux, I, Hoën, B, Delfraissy, Jf, Meyer, L, Rouzioux, C, Group, Optiprim Anrs Study

Get full text

COL05-02 : Résultats de l’essai OPTIPRIM-ANRS 147 by Chéret, A., Mélard, A., Nembot, G., Lascoux, C., Reynes, J., Meyer, L., Rouzioux, C.

Get full text

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial by Chéret, Antoine, Dr, Nembot, Georges, MD, Mélard, Adeline, MSc, Lascoux, Caroline, MD, Slama, Laurence, MD, Miailhes, Patrick, MD, Yeni, Patrick, Prof, Abel, Sylvie, MD, Avettand-Fenoel, Véronique, PharmD, Venet, Alain, MD, Chaix, Marie-Laure, MD, Molina, Jean-Michel, Prof, Katlama, Christine, Prof, Goujard, Cécile, Prof, Tamalet, Catherine, MD, Raffi, François, Prof, Lafeuillade, Alain, MD, Reynes, Jacques, Prof, Ravaux, Isabelle, MD, Hoën, Bruno, Prof, Delfraissy, Jean-François, Prof, Meyer, Laurence, Prof, Rouzioux, Christine, Prof

Get full text

Application of polyethylene glycol 8000 as plasticizer for the development of ellagic acid and Eudragit® EPO based solid dispersions using hot melt extrusion by Nyamba, Isaie, Nembot, Alexis M W, Sombié, Bavouma Charles, Zimé-Diawara, Hermine, Yaméogo, B. G. Josias, Lechanteur, Anna, Damblon, Christian, Semdé, Rasmané, Evrard, Brigitte

Get full text

Valuing the Cameroonian forest Editorial by LESCUYER, G., ATYI, R. EBA’A, NASI, R., NEMBOT, T. FOMETE

Get full text

Building on Capacity Established through US Centers for Disease Control and Prevention Global Health Programs to Respond to COVID-19, Cameroon by Dokubo, Emily Kainne, Shang, Judith D, N'Dir, Adama, Ndongmo, Clement B, Okpu, Gordon, Fadil, Yasmine Moussa, Takang, Laura Eno, Angumua, Carrine, Lyonga, Esther, Mayer, Magdalene, Ayukotabe, Tabiayuk, Nkwoh, Tse K, Hedje, Judith, Etoundi, Georges A, Njock, Richard L

Get full text

Valuing the Cameroonian forest by Lescuyer, G, Atyi, R. Eba'a, Nasi, R, Nembot, T. Fomete

Get full text

Editorial - Valuing the Cameroonian Forest by Lescuyer, G., Atyi, R. Eba'a, Nasi, R., Nembot, T. Fomete

Get full text